Literature DB >> 23317289

Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer.

C Zhan1, Y Shi, C Lu, Q Wang.   

Abstract

It's frequently stated that the pyruvate kinase M2 (PKM2) and Warburg effect are important for cancer development by accumulating more raw materials for macromolecule biosynthesis. However, the correlation between PKM2 and cancer is poorly reported. Here, we investigated the PKM2 expression in esophageal squamous cell cancer (ESCC). We observed that the expression of PKM2 was much higher in ESCC than in control normal tissue, and it is highly associated with many clinical features and prognosis. Specially, we found that the expression of PKM2 was closely related to the differentiation state of ESCC, and we further confirmed this discovery in vitro. As a result, out data indicated that PKM2 might be a useful indicator for determining the survival of patients with ESCC. Considering previous researches on the link among PKM2, Warburg effect, and differentiation, our study inferred the direct roles of PKM2 and Warburg effect in the differentiation of cancer cells rather than only providing synthetic intermediates for the promotion of cancer's progression.
© 2013 Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Keywords:  ESCC; PKM2; Warburg effect; differentiation; prognosis

Mesh:

Substances:

Year:  2013        PMID: 23317289     DOI: 10.1111/dote.12023

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  20 in total

Review 1.  Drugging cancer metabolism: Expectations vs. reality.

Authors:  David C Montrose; Lorenzo Galluzzi
Journal:  Int Rev Cell Mol Biol       Date:  2019-07-29       Impact factor: 6.813

2.  Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma.

Authors:  Cheng Zhan; Li Yan; Lin Wang; Yang Sun; Xingxing Wang; Zongwu Lin; Yongxing Zhang; Yu Shi; Wei Jiang; Qun Wang
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

3.  Mutations and expression of the NFE2L2/KEAP1/CUL3 pathway in Chinese patients with lung squamous cell carcinoma.

Authors:  Yongxing Zhang; Hong Fan; Shuo Fang; Lin Wang; Li Chen; Yulin Jin; Wei Jiang; Zongwu Lin; Yu Shi; Cheng Zhan; Qun Wang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.

Authors:  Naoya Yoshida; Yoshifumi Baba; Hironobu Shigaki; Kazuto Harada; Masaaki Iwatsuki; Yasuo Sakamoto; Yuji Miyamoto; Junji Kurashige; Keisuke Kosumi; Ryuma Tokunaga; Masayuki Watanabe; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2016-06-02       Impact factor: 3.402

5.  Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets.

Authors:  Q-X Huang; J-Y Cui; H Ma; X-M Jia; F-L Huang; L-X Jiang
Journal:  Cancer Gene Ther       Date:  2015-12-18       Impact factor: 5.987

6.  PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.

Authors:  Chenggang Li; Zhiming Zhao; Zhipeng Zhou; Rong Liu
Journal:  Dig Dis Sci       Date:  2015-10-24       Impact factor: 3.199

7.  Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.

Authors:  Cheng Zhan; Li Yan; Lin Wang; Jun Ma; Wei Jiang; Yongxing Zhang; Yu Shi; Qun Wang
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

8.  Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.

Authors:  Shruti Desai; Minming Ding; Bin Wang; Zhimin Lu; Qi Zhao; Kenna Shaw; W K Alfred Yung; John N Weinstein; Ming Tan; Jun Yao
Journal:  Oncotarget       Date:  2014-09-30

9.  Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms.

Authors:  Kohei Taniguchi; Yuko Ito; Nobuhiko Sugito; Minami Kumazaki; Haruka Shinohara; Nami Yamada; Yoshihito Nakagawa; Tarou Sugiyama; Manabu Futamura; Yoshinori Otsuki; Kazuhiro Yoshida; Kazuhisa Uchiyama; Yukihiro Akao
Journal:  Sci Rep       Date:  2015-02-27       Impact factor: 4.379

10.  Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.

Authors:  Li Yan; Cheng Zhan; Jihong Wu; Shengzi Wang
Journal:  Mol Med Rep       Date:  2016-03-28       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.